TI
Live price temporarily unavailable.
Price history
Instil Bio (TIL) is a Health Care company. Latest news and coverage below.
IPO: March 19, 2021 · $20.00 offering · NASDAQ · View IPO details →
Instil Bio revenue & net income history (FY2020–FY2025)
RevenueNet income
| FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $138.0K | $0 | — | — | — | — |
| Growth (year over year) | — | −100.0% | — | — | — | — |
| Operating income | −$33.6M | −$155.6M | −$226.5M | −$159.2M | −$73.5M | −$78.6M |
| Operating margin | −24379.7% | — | — | — | — | — |
| Net income | −$37.7M | −$156.8M | −$223.2M | −$156.1M | −$74.1M | −$71.4M |
| Net margin | −27346.4% | — | — | — | — | — |
| EPS (diluted) | −$47.20 | −$29.60 | −$34.46 | −$24.00 | −$11.39 | −$10.70 |
| Balance sheet | ||||||
| Cash and equivalents | $241.7M | $37.6M | $43.7M | $9.20M | $8.80M | $6.64M |
| Total assets | $319.0M | $610.0M | $482.1M | $325.6M | $263.6M | $203.5M |
| Total liabilities | $26.6M | $54.8M | $118.5M | $99.8M | $94.1M | $89.7M |
| Shareholders' equity | −$39.6M | $555.2M | $363.6M | $225.8M | $169.4M | $113.9M |
| Cash flow | ||||||
| Operating cash flow | −$29.6M | −$122.1M | −$180.2M | −$82.0M | −$55.7M | −$36.6M |
| Capital expenditure | $50.8M | $57.8M | $84.6M | $20.7M | $0 | — |
| Free cash flow | −$80.4M | −$180.0M | −$264.8M | −$102.7M | −$55.7M | — |
Net income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | −$23.6M | −$11.8M | −$30.6M | −$23.4M | −$15.0M | −$9.56M | −$7.01M | −$5.58M |
| Net income | −$23.0M | −$11.9M | −$28.2M | −$21.4M | −$13.6M | −$8.19M | −$4.20M | −$4.30M |
| EPS (diluted) | −$3.54 | −$1.82 | −$4.32 | −$3.24 | −$2.01 | −$1.13 | −$0.62 | −$0.63 |
| Balance sheet | ||||||||
| Cash and equivalents | $6.66M | $8.80M | $15.4M | $7.69M | $5.80M | $6.64M | $5.02M | $5.54M |
| Total assets | $272.6M | $263.6M | $237.4M | $231.0M | $211.8M | $203.5M | $200.4M | $197.7M |
| Total liabilities | $96.2M | $94.1M | $92.5M | $99.3M | $91.3M | $89.7M | $89.7M | $90.3M |
| Shareholders' equity | $176.3M | $169.4M | $144.9M | $131.7M | $120.4M | $113.9M | $110.7M | $107.4M |
| Cash flow | ||||||||
| Operating cash flow | −$20.1M | −$10.6M | −$4.20M | −$14.8M | −$10.6M | −$7.08M | −$1.34M | −$4.64M |
| Capital expenditure | $0 | $0 | — | — | — | — | — | — |
| Free cash flow | −$20.1M | −$10.6M | — | — | — | — | — | — |
From Instil Bio's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Instil Bio
- Headquarters
- Dallas, Texas From SEC filings, Oct 2026
Recent News (1)
Other Health Care companies to compare with TIL
- TENX Tenax Therapeutics
- TFX Teleflex
- TGTX Tg Therapeutics Inc
- THC Tenet Healthcare
- TKNO Alpha Teknova Inc
- TLRY Tilray Brands
- TLSI Trisalus Lf Sc Cm a
- TMCI Treace Medical Concepts Inc